SEC Form 4 · accession 0001140361-16-072820
Asterias Biotherapeutics, Inc. · AST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Daniel Chavez
Officer — Exec. VP of Fin & Gen. Counsel
Period of report
Jul 18, 2016
Accepted (ET)
Jul 19, 2016 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001572552
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $2.91 | Jul 18, 2016 | A | 380,000 | A | Jul 18, 2016 | Jul 18, 2026 | Common Stock | 380,000 | 380,000 | D |
Explanation of responses
- F1The stock options reported herein vest as follows: one quarter of the options vest upon the completion of 12 full months of the Reporting Person's continuous service with the Issuer, measured from the date of the grant, and the balance of the options vest in 36 equal monthly installments commencing on the first anniversary of the date of the grant, based upon the completion of each month of continuous service by the Reporting Person.